Back to top

Craig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)

Craig-Hallum analyst Chase Knickerbocker reiterated a Buy rating on scPharmaceuticals (SCPH – Research Report) on May 15 and set a price target of ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

scPharmaceuticals, Inc. (SCPH)